Paper

Beta blockers in the management of chronic kidney disease.

Published Dec 1, 2006 · G. Bakris, E. Ritz, P. Hart

Kidney international

185

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Literature Review

Highly Cited

Study Snapshot

Greater use of vasodilating beta-blockers in chronic kidney disease patients with hypertension could reduce the risk of heart failure and improve renal disease progression.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Beta blockers in the management of chronic kidney disease.

References

Citations